Oncolytics Biotech Inc. (ONCY)

[onco_investor]

Randomized PhII Colon trial combo w/FOLFOX-6 plus Avastin will be the second trial sponsored and conducted by the NCIC Clinical Trials Group (CTG)

http://ih.advfn.com/p.php?pid=nmona&article=52266413&symbol=ONCY

This trial has been long in coming but another Phase II trial paid for by somebody else and hmmmmmm, who makes Avastin?

Key parts of this announcement in my mind are:

NCIC Clinical Trials Group (CTG) at Queen's University in Kingston, Ontario, will sponsor and conduct a randomized Phase II study of REOLYSIN® in patients with advanced or metastatic colorectal cancer.

Approximately 50 response evaluable patients will be enrolled in each arm, after a six to nine patient safety run in.

The NCIC Clinical Trials Group (NCIC CTG) is a cancer clinical trials cooperative group that conducts Phase I-III trials testing anti-cancer and supportive therapies across Canada and internationally. It is a national research program of the Canadian Cancer Society.

More than 60 member institutions, from major cancer centres to community hospitals, enroll patients in NCIC Clinical Trials Group studies.


Enrollment should be fast after the first 9 with 100 patients total planned and 60 centers enrolling.

Each indication Reolysin is tested in makes the potential steadily grow with each indication advanced into Phase II trials.